title: Anakinra delayed skin allergy expressing as both injection site reactions and generalized exanthema.
authors.affiliation: Department of Allergy and Clinical Immunology, Hospital Center Lyon Sud, 69495 Pierre Bénite, France.
authors.forename: Elena R
authors.initials: ER
authors.lastname: Lungoci
authors.affiliation: Department of Allergy and Clinical Immunology, Hospital Center Lyon Sud, 69495 Pierre Bénite, France.
authors.forename: Florence
authors.initials: F
authors.lastname: Hacard
authors.affiliation: Department of Allergy and Clinical Immunology, Hospital Center Lyon Sud, 69495 Pierre Bénite, France, Inserm U1111-CIRI, Lyon, France.
authors.forename: Jean-François
authors.initials: JF
authors.lastname: Nicolas
authors.affiliation: Department of Allergy and Clinical Immunology, Hospital Center Lyon Sud, 69495 Pierre Bénite, France, University Lyon 1, France.
authors.forename: Frédéric
authors.initials: F
authors.lastname: Berard
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000188:drug therapy*; D003875:Drug Eruptions / Q000209:etiology* / Q000503:physiopathology; D004342:Drug Hypersensitivity / Q000175:diagnosis / Q000209:etiology*; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000175:diagnosis / Q000209:etiology*; D007279:Injections, Subcutaneous / Q000009:adverse effects; D053590:Interleukin 1 Receptor Antagonist Protein / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D018570:Risk Assessment; D012720:Severity of Illness Index; D012882:Skin Tests
chemical_list: D018501:Antirheumatic Agents; D053590:Interleukin 1 Receptor Antagonist Protein